Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Phase II Study In Patients With Advanced Head And Neck Cancer Of Standard Chemoradiation And Add-On Cetuximab

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2011 by University of Zurich
Sponsor:
Information provided by (Responsible Party):
Oliver Riesterer, University of Zurich
ClinicalTrials.gov Identifier:
NCT01435252
First received: July 26, 2011
Last updated: September 15, 2011
Last verified: September 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: November 2015
  Estimated Primary Completion Date: November 2015 (Final data collection date for primary outcome measure)